University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, United States.
University of Maryland, Department of Pharmaceutical Sciences, 20 Penn Street, Baltimore, MD 21201, United States.
Eur J Pharm Sci. 2022 Jul 1;174:106210. doi: 10.1016/j.ejps.2022.106210. Epub 2022 May 14.
A previously developed model showed good predictability for in vitro drug dissolution into FeSSGF and FeSSIF-V2, where biorelevant media-mediated enhanced drug dissolution by only about one-tenth as much as it enhanced solubility, due to drug-loaded fat globules and mixed micelles exhibiting far slower diffusivity than free drug. The present objective was to quantitatively assess the contributions of fasted biorelevant media-mediated solubility and diffusivity on enhanced drug dissolution in FaSSGF and FaSSIF-V2. Griseofulvin, ketoconazole, and ibuprofen were subjected to dissolution into FaSSGF and FaSSIF-V2, as well as their corresponding "surfactant-free" media. Solubility and dynamic light-scattering studies (DLS) of drug in FaSSGF and FaSSIF-V2 were conducted. Results showed that FaSSGF and FaSSIF-V2 mixed micelles were large and slowly diffusing (diffusivities about 2 × 10 cm/s and 12×10 cm/s, respectively), compared to free drug (about 7 × 10 cm/s), although were smaller and more rapidly diffusing compared to drug-bound fat globules and mixed micelles from FeSSGF and FeSSIF-V2 (about 1 × 10 cm/s and 7 × 10 cm/s, respectively). Dissolution enhancement in FaSSGF and FaSSIF-V2 was the same as solubility enhancement, which was minimal. FaSSGF and FaSSIF-V2 practically did not enhance drug dissolution, since solubility was at best minimally increased, but also since micelles were relatively slowly diffusing relative to free drug diffusivity.
先前开发的模型在预测药物在 FeSSGF 和 FeSSIF-V2 中的体外溶出度方面表现良好,其中生物相关介质介导的药物溶出度增强约为溶解度增强的十分之一,这是由于载药脂肪球和混合胶束的扩散性远低于游离药物。本研究旨在定量评估空腹生物相关介质介导的溶解度和扩散性对 FaSSGF 和 FaSSIF-V2 中药物溶出度增强的贡献。灰黄霉素、酮康唑和布洛芬分别在 FaSSGF 和 FaSSIF-V2 及其相应的“无表面活性剂”介质中进行溶出度研究。对 FaSSGF 和 FaSSIF-V2 中药物的溶解度和动态光散射(DLS)进行了研究。结果表明,与游离药物(约 7×10 cm/s)相比,FaSSGF 和 FaSSIF-V2 的混合胶束较大且扩散缓慢(扩散系数分别约为 2×10 cm/s 和 12×10 cm/s),尽管与 FeSSGF 和 FeSSIF-V2 中的药物结合脂肪球和混合胶束相比,它们更小且扩散更快(分别约为 1×10 cm/s 和 7×10 cm/s)。FaSSGF 和 FaSSIF-V2 中的溶出度增强与溶解度增强相同,均为最小。FaSSGF 和 FaSSIF-V2 实际上并没有增强药物的溶出度,因为溶解度的增加最多是最小的,而且胶束的扩散速度相对于游离药物的扩散速度相对较慢。